Advances and Challenges in Treatment of Locally Advanced Rectal Cancer
- 1 June 2015
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (16), 1797-1808
- https://doi.org/10.1200/jco.2014.60.1054
Abstract
Dramatic improvements in the outcomes of patients with rectal cancer have occurred over the past 30 years. Advances in surgical pathology, refinements in surgical techniques and instrumentation, new imaging modalities, and the widespread use of neoadjuvant therapy have all contributed to these improvements. Several questions emerge as we learn of the benefits or lack thereof for components of the current multimodality treatment in subgroups of patients with nonmetastatic locally advanced rectal cancer (LARC). What is the optimal surgical technique for distal rectal cancers? Do all patients need postoperative chemotherapy? Do all patients need radiation? Do all patients need surgery, or is a nonoperative, organ-preserving approach warranted in selected patients? Answering these questions will lead to more precise treatment regimens, based on patient and tumor characteristics, that will improve outcomes while preserving quality of life. However, the idea of shifting the treatment paradigm (chemoradiotherapy, total mesorectal excision, and adjuvant therapy) currently applied to all patients with LARC to a more individually tailored approach is controversial. The paradigm shift toward organ preservation in highly selected patients whose tumors demonstrate clinical complete response to neoadjuvant treatment is also controversial. Herein, we highlight many of the advances and resultant controversies that are likely to dominate the research agenda for LARC in the modern era.Keywords
This publication has 119 references indexed in Scilit:
- Evolving Role of Neoadjuvant Therapy in Rectal CancerCurrent Treatment Options in Oncology, 2013
- Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trialBMC Cancer, 2013
- Optimal Timing of Surgery After Chemoradiation for Advanced Rectal CancerAnnals of Surgery, 2011
- Local staging of rectal cancer: A review of imagingJournal of Magnetic Resonance Imaging, 2011
- Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancerBritish Journal of Surgery, 2010
- Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trialThe Lancet Oncology, 2010
- Oncologic Outcomes of Robotic-Assisted Total Mesorectal Excision for the Treatment of Rectal CancerAnnals of Surgery, 2010
- Is the Increasing Rate of Local Excision for Stage I Rectal Cancer in the United States Justified?Annals of Surgery, 2007
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Impact of a surgical training programme on rectal cancer outcomes in StockholmBritish Journal of Surgery, 2004